Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
Asbestos Diseases Research Institute · University of Sydney · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
706
total citations
- FWCI
- 18.59
- Percentile
- 100%
- References
- 38
Citations per year
Authors
17- NVNico van ZandwijkCorresponding
Asbestos Diseases Research Institute, University of Sydney
- NPNick Pavlakis
University of Sydney, Northern Cancer Institute
- SKSteven Kao
University of Sydney, Chris O’Brien Lifehouse, Asbestos Diseases Research Institute
- ALAnthony Linton
Concord Repatriation General Hospital
- MBMichael Boyer
University of Sydney, Chris O’Brien Lifehouse
Topics & keywords
Topics
Keywords
- Mesothelioma
- Medicine
- Pathology
- Cancer research
- Oncology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.